sabamirzaMay 7

Bayer Stock jumps after $2.45B Perfuse deal reshapes future pharmaceutical innovation strategy globally.

#BayerStock #PharmaNews #StockMarket #HealthcareInvesting

https://meyka.com/blog/bayer-stock-may-7-245b-perfuse-deal-signals-pharma-shift-0705/

Bayer Stock May 7: $2.45B Perfuse Deal Signals Pharma Shift | Meyka

Bayer acquires Perfuse Therapeutics for $2.45B to strengthen ophthalmology portfolio with PER-001 drug candidate, addressing Eylea patent risks.